Cite
Lange T, Valentiner U, Wicklein D, et al. Tumor cell E-selectin ligands determine partial inhibitory efficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo. Mol Ther. 2022;doi: 10.1016/j.ymthe.2022.01.017.
Lange, T., Valentiner, U., Wicklein, D., Maar, H., Labitzky, V., Ahlers, A. K., Starzonek, S., Genduso, S., Staffeldt, L., Pahlow, C., Dück, A. M., Stürken, C., Baranowsky, A., Bauer, A. T., Bulk, E., Schwab, A., Riecken, K., Börnchen, C., Kiefmann, R., Abraham, V., DeLisser, H. M., Gemoll, T., Habermann, J. K., Block, A., Pantel, K., & Schumacher, U. (2022). Tumor cell E-selectin ligands determine partial inhibitory efficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo. Molecular therapy : the journal of the American Society of Gene Therapy, . https://doi.org/10.1016/j.ymthe.2022.01.017
Lange, Tobias, et al. "Tumor cell E-selectin ligands determine partial inhibitory efficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo." Molecular therapy : the journal of the American Society of Gene Therapy vol. (2022). doi: https://doi.org/10.1016/j.ymthe.2022.01.017
Lange T, Valentiner U, Wicklein D, Maar H, Labitzky V, Ahlers AK, Starzonek S, Genduso S, Staffeldt L, Pahlow C, Dück AM, Stürken C, Baranowsky A, Bauer AT, Bulk E, Schwab A, Riecken K, Börnchen C, Kiefmann R, Abraham V, DeLisser HM, Gemoll T, Habermann JK, Block A, Pantel K, Schumacher U. Tumor cell E-selectin ligands determine partial inhibitory efficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo. Mol Ther. 2022 Jan 11; doi: 10.1016/j.ymthe.2022.01.017. Epub 2022 Jan 11. PMID: 35031433.
Copy
Download .nbib